The effects of N-acetylcysteine on cisplatin induced cardiotoxicity

被引:23
作者
Gunturk, E. E. [1 ]
Yucel, B. [1 ,2 ]
Gunturk, P. [1 ,3 ]
Yazici, C. [1 ,4 ]
Yay, A. [1 ,5 ]
Kose, K. [1 ,4 ]
机构
[1] Nigde Omer Halisdemir Univ, Fac Med, Dept Cardiol, Nigde, Turkey
[2] Izmir Konak Publ Hlth Lab, Dept Biochem, Izmir, Turkey
[3] Nigde Omer Halisdemir Univ, Sch Hlth, Dept Midwifery, Nigde, Turkey
[4] Erciyes Univ, Fac Med, Dept Biochem, Kayseri, Turkey
[5] Erciyes Univ, Fac Med, Dept Histol & Embryol, Kayseri, Turkey
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2019年 / 120卷 / 06期
关键词
rats; cisplatin; oxidative stress; cardiotoxicity; N-acetylcysteine; BIOCHEMICAL MARKERS; INDUCED NEPHROTOXICITY; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; HEART; DOXORUBICIN; PREVENTION; TISSUE; ACID;
D O I
10.4149/BLL_2019_068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Recent studies reported that oxidative stress is an important mechanism that contributes to cisplatin induced cardiotoxicity. In the present study, the effects of N-acetylcysteine (NAC), which is an antioxidant, on cisplatin induced cardiotoxicity were investigated in a rat model. METHODS: Thirty two rats were separated into 4 equal groups: Control, NAC-250, CP (cisplatin), CP+NAC. Rats in the experimental groups were treated with a single dose of cisplatin intraperitoneally (ip) (10 mg/kg) and NAC (ip, 250 mg/kg) for 3 consecutive days. At the end of the experiment, cardiotoxicity was determined from plasma CK-MB, LDH, cTnI and cardiac myosin light chain-1 (CMLC-1) levels. In the tissue samples, total oxidant capacity (TOC), total antioxidant capacity (TAC), lipid hydroperoxide (ROOH) and thiol levels were measured. The hearts were also analyzed histopathologically. RESULTS: It was determined that cisplatin increased the tissue TOC, ROOH levels and decreased TAC and thiol levels. NAC administration after cisplatin treatment was observed to have ameliorated histological and functional changes in heart. CONCLUSIONS: In conclusion, the results of this experimental study suggested that oxidative stress had a serious effect on cisplatin cardiotoxicity, and NAC could be used as a therapeutic agent in addition to standard cisplatin treatment protocols (Tab. 3, Fig. 1, Ref. 35). Text in PDF www.elis.sk.
引用
收藏
页码:423 / 428
页数:6
相关论文
共 36 条
[1]   Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: A biochemical, histopathological, and immunohistochemical study [J].
Abdellatief, Suhair A. ;
Galal, Azza A. A. ;
Farouk, Sameh M. ;
Abdel-Daim, Mohamed M. .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 86 :482-491
[2]   Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention [J].
Albini, Adriana ;
Pennesi, Giuseppina ;
Donatelli, Francesco ;
Cammarota, Rosaria ;
De Flora, Silvio ;
Noonan, Douglas M. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (01) :14-25
[3]   Cisplatin nephrotoxicity [J].
Arany, I ;
Safirstein, RL .
SEMINARS IN NEPHROLOGY, 2003, 23 (05) :460-464
[4]  
Bano N., 2013, Int J Pharm Sci Rev Res, V18, P80
[5]   Biomarkers for monitoring chemotherapy-induced cardiotoxicity [J].
Cao, Liyun ;
Zhu, Wuqiang ;
Wagar, Elizabeth A. ;
Meng, Qing H. .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2017, 54 (02) :87-101
[6]   Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses [J].
Chowdhury, Sayantani ;
Sinha, Krishnendu ;
Banerjee, Sharmistha ;
Sil, Parames C. .
BIOFACTORS, 2016, 42 (06) :647-664
[7]   The protective effect of thiamine pyrophosphate, but not thiamine, against cardiotoxicity induced with cisplatin in rats [J].
Coskun, Resit ;
Turan, Mehmet Ibrahim ;
Turan, Isil Siltelioglu ;
Gulaboglu, Mine .
DRUG AND CHEMICAL TOXICOLOGY, 2014, 37 (03) :290-294
[8]  
D'Agostini F, 1998, INT J ONCOL, V13, P217
[9]   Cisplatin in cancer therapy: Molecular mechanisms of action [J].
Dasari, Shaloam ;
Tchounwou, Paul Bernard .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 :364-378
[10]  
DeFlora S, 1996, INT J CANCER, V67, P842, DOI 10.1002/(SICI)1097-0215(19960917)67:6<842::AID-IJC14>3.0.CO